instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: The Alpine republic with a population of 8.8 million has tested around 28,400 people so far with nearly 4,900 cases and 28 deaths confirmed. It was one of the first European countries to put severe restrictions on movement and close shops and schools in response to the developments in neighboring Italy and a strong increase in coronavirus infections in its western regions. In coming weeks, Austria plans to test up to 15,000 people per day, the chancellor said. "We will also launch rapid tests, to test hundreds of thousands of people, as quickly as possible," Kurz told a news conference. He referred to brand new tests that are comparably cheap but take longer than laboratory tests used up until now. Broad testing is key to getting a clear picture of the real infection rate and an idea of how many people have developed immunity against the virus, the chancellor said. Top priority was to delay the peak of infections as long as possible to avoid a situation like in Italy or Spain, where the health systems are overwhelmed. "Our goal is that the number of infections doubles only every 14 days and not every two, three or five days and that we will set the right measures to keep it that way once we ramp up social life again," Kurz said. Austria's strict measures are in place until April 13, and Kurz said there was hope that a gradual withdrawal could start the day after. A government task force developing scenarios for the "ramp up" was currently dealing with questions such as in which order schools, businesses and production should restart. Lessons from other countries showed that it was crucial to remain disciplined and to make use of "big data". Asked what he meant by "big data", Kurz said: "We are currently working with the Red Cross and other enterprises on ideas that could be implemented in Austria and in Europe, and which are suitable for our system and our democracy." Austria's Red Cross is promoting a so-called "Stop Corona" app, which enables a user to digitally store who he meets and when. If a person shows symptoms of corona disease, these contact persons can be notified. Austria's mobile carrier A1 Telekom Austria is already sharing results from a motion analysis application that visualizes the movement flows of groups of people with the health authority. Claim: Austria bets on mass testing to manage coronavirus spread.
answer:
Austria will massively expand coronavirus testing in coming days to locate and isolate infected people and avoid an Italian-like overload of its health system, Chancellor Sebastian Kurz said on Tuesday.

question:
Paragraph: There was no mentionof the potential costs of screening women for vitamin D levels (as encouraged in the release in a statement from the principal investigator) or the cost of supplementation. The release does a good job of comparing data and providing explanations for the measurements used. We'll award a Satisfactory for that precision, but as noted below under "Evidence," there was no explicit caution regarding the fact that measurements of interleukin-6 (IL-6) are only surrogates for the effects of weight loss and vitamin D on clinical outcomes related to inflammation (e.g. cancer diagnoses). IL-6 levels dropped in both the placebo and vitamin D arms, and it's not clear whether the statistically significant additional decline in IL-6 observed in the vitamin D group is clinically important. Because some of the participants were vitamin D-deficient and the dose of vitamin D provided was modest (2000 IU/d), this was a tough call. But supplementation is often so misunderstood, overhyped and oversold that some statement cautioning readers to pay attention to the specifics of this study and not apply its recommendations to everyone seems prudent. For the most part, the release provides a cautious and accurate description of what appears to be a well-conducted clinical trial in a well-defined population. For example, itnotes that weight loss and vitamin D lowered inflammation LINKED to cancer not that these things reduced cancer risk itself (something this study couldn't establish). But as noted above, we would have appreciated an explicit acknowledgment that IL-6 is a surrogate marker for the clinical outcomes that people care about. And more importantly, we're concerned about the closing commentthat women should talk to their doctors about measuring their vitamin D levels to determine the most appropriate dose. The problem is there is no evidence supporting screening or treating to a level and certainly not from this study. The US Preventive Services Task Force has concluded that evidence is insufficient to recommend routine vitamin D screening and the IOM has said that while there are data supporting the benefitsof vitamin D supplementation with bone health and fall prevention, there is no evidence supporting benefits for cancer. While testing may be warranted in those with signs or symptoms of clinical deficiency, the statement made here implies that everyone should be tested so that an appropriate dose of vitamin D can be selected. That goes beyond the available evidence. It's hard to argue that overweight, vitamin deficiency, chronic inflammation and cancer are not real threats, so no mongeringapparent here. Funding sources are well documented. The study didn't discuss alternative preventive measures or genetic causes of increased cancer risks. But this is such a broad and expansive topic that we don't think the release should have been expected to address those myriad issues. We'll rate this Not Applicable. Primary care physicians and other health providers are well positioned to monitor blood levels of vitamin D, along with dietary and exercise regimens. The news release makes that clear, albeit indirectly. As noted above, we think the release goes too far in suggesting that people ask their doctors about having their vitamin D levels checked. But we've already docked points for that, so we'll award a Satisfactory rating here. The release makes a case for this being the first clinical trial of its kind; although it's always difficult to make that statement absolutely, the writer of the release attributes the statement to the study author. As a general rule, it's probably best to say "believed to be the first." While the release meets our standard here, we also wish it had delved a bit into the background of previous vitamin D research and the conflicting and confusing messages that research has generated. Without that context, the typical reader might wronglyjump to the conclusion, based on the wording of the lede and other parts of the release, that this study of vitamin D supplementation because it was a controlled clinical trial has somehow settled the important questions about the role of vitamin D and inflammation in cancer risk. The debate remains alive and well. None detected. Claim: Weight loss plus vitamin D reduces inflammation linked to cancer, chronic disease
answer:
This news release describes a randomized, controlled clinical trial designed to learn whether adding vitamin D supplements to substantial weight loss regimens would have a synergistic effect in reducing inflammatory chemicals in the bodies of overweight, older women with levels of vitamin D considered too low. The study, published inCancer Prevention Research, has potential relevance for cancer prevention because inflammatory cytokines have been implicated in the genesis and progression of some cancers, as well as heart disease and other disorders. The release offers substantial details about the design, metrics and outcomes of the clinical trial and does a pretty good job of defining the possible reasons for the effects of chronic inflammation and weight loss on cancer development. It goes to some lengths to narrowly define the results and avoid overstatement. That said, the release ends on a sour note by encouraging readers to talk to their doctors about vitamin D testing a recommendation not consistent with U.S. Preventive Services Task Force guidelines and which is not supported by this research. Readers might also have been better informed if the release had offered more context regarding the many conflicting and sometimes confusing studies that have previously looked for links among vitamin D, inflammatory responses, diet, overweight, sun exposure and cancer. News releases that include the words "diet," "overweight," "vitamin," and "cancer" are almost narrative nuclear events, often guaranteeing an explosion of coverage, souped up vitamin sales pitches, and lots of negative fallout whose half-life seems forever. Cancer remains the second biggestkiller disease overall of Americans, and some experts believe that it will soon pushheart disease and stroke out of first place. Thus cancer prevention is a deservedly hot topic, and it is no surprise that Americans are eager for information about ways to limit their risk. News releases that describe research on these topics have enormous power to inform and misinform.

question:
Paragraph: The government expects to make Spain the fourth country in Europe to decriminalize euthanasia and assisted suicide before its terms ends in 2020. Right now, helping someone end their life carries a jail term of up to 10 years, and while there are still pockets of resistance in the traditionally Catholic country to dispensing with that penalty, for Lopez the debate is over. The 49-year-old former businessman was diagnosed with amyotrophic lateral sclerosis (ALS) just over a year ago. He can no longer walk or move his right hand, the first stage of a degenerative process in which sufferers lose the ability to speak, eat and finally breathe. "It advances rapidly ... When a moment comes I want to have the option of deciding whether the life as it is offered to me, is worth it. And if it's not, I want to end it," Lopez told Reuters in a soft voice, his speech slightly slurred. The Catholic Church - long a lodestone for public opinion in Spain - considers euthanasia to be morally wrong, and the main conservative opposition People's Party (PP) also wants it to remain a criminal offense. But the church's influence has been on the wane ever since Francisco Franco's dictatorship ended in 1975. The most recent national opinion poll taken last year showed 84 percent support for euthanasia, and most parties other than the PP have said they will back the minority Socialist government's demineralization bill. The previous Socialist administration demonstrated its liberal credentials in 2005, when Spain became the third country in the world to allow same-sex marriage. Euthanasia has long grabbed public attention in Spain, which has the world's second-highest life expectancy, and more notably so since Oscar-winning Spanish film 'The Sea Inside'. The 2004 film was based on the story of Ramon Sampedro, a paralyzed man who for decades campaigned for the legal right to die. Courts denied him that right but he committed assisted suicide nonetheless. This is set to change, but Lopez's hopes for the bill's quick passage are mixed with concern that case-by-case evaluations it proposes could be a hindrance when the time comes to decide. He calls euthanasia "an intimate process", leaving a person free to end a life that has become physically or psychologically unbearable, and would not say how he would proceed if it remained illegal. ALS, also known as Lou Gehrig's disease, destroys neural links between the brain and the muscles. Most sufferers die within 3-5 years and it affects about 4,000 people in Spain. A year ago, Lopez worked, played golf and cycled, seven months ago he could still drive a car. Now he relies on an electric wheelchair and his father, 78, helps him dress. Breathing problems have become a torture, he says. "In my head, I dream I'm riding a bicycle, going somewhere, but the truth is I can't even go to the bathroom by myself," he told said at his sister's home outside Madrid where he moved after his diagnosis. Lopez plays with his niece who likes to press buttons on his wheelchair, exchanges jokes and small talk with his physical therapist and doctors, and says he wants his family to see him strong, "so they can move forward". His 46-year-old sister Gema has not yet come to terms with the brother's decision, but says his bravery must be respected. "If he wants to go on his own terms, it will be done so, no matter what anyone thinks or says," she said. Claim: As Spain readies euthanasia law, dying sclerosis victim senses hope.
answer:
Painfully aware that his advancing illness will eventually leave him on life support, Spaniard Mariano Lopez has his hopes pinned not on a cure but on a parliamentary bill that would allow him to meet death on his own terms.